The Exploration of 18F-PSMA-1007 PET/CT Imaging in Prostate Cancer Patients

NCT06723665 · clinicaltrials.gov ↗

NA

Phase

ENROLLING_BY_INVITATION

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: 18F-PSMA-1007
DRUG: 18F-FDG

Sponsor

Affiliated Hospital of Jiangnan University